Gelsolin as a Potential Clinical Biomarker in Psoriasis Vulgaris
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sul Hee | - |
dc.contributor.author | Park, Young-Lip | - |
dc.contributor.author | Bae, Youin | - |
dc.date.accessioned | 2023-05-01T07:40:09Z | - |
dc.date.available | 2023-05-01T07:40:09Z | - |
dc.date.issued | 2023-03 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/22396 | - |
dc.description.abstract | Although discovering novel biomarkers for psoriasis is challenging, it may play an essential role in diagnosis, severity assessment, and prediction of treatment outcome and prognosis. The study was aimed to determine potential serum biomarkers of psoriasis via proteomic data analysis and clinical validity assessment. Thirty-one subjects manifested psoriasis and 19 subjects were healthy volunteers who were enrolled in the study. Protein expression was performed via two-dimensional gel electrophoresis (2-DE) using psoriasis patients' sera before and after treatment and sera of patients without psoriasis. Image analysis was then performed. Nano-scale liquid chromatography-tandem mass spectrometry (LC-MS/MS) experiments subsequently identified points showing differential expression in 2-DE image analysis. To measure levels of candidate proteins to validate results obtained from 2-DE, enzyme linked immunosorbent assay (ELISA) was then conducted. Gelsolin was identified as a potential protein through LC-MS/MS analysis and database search. Serum gelsolin levels were lower in the groups of psoriasis patients before treatment than in the control group and the group of psoriasis patients after treatment. Additionally, in subgroup analysis, serum gelsolin level was correlated with various clinical severity scores. In conclusion, low serum gelsolin levels are associated with the severity of psoriasis, proposing the potential role of gelsolin as a biomarker for severity assessment and evaluation of treatment response of psoriasis. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI AG | - |
dc.title | Gelsolin as a Potential Clinical Biomarker in Psoriasis Vulgaris | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/jcm12051801 | - |
dc.identifier.scopusid | 2-s2.0-85149927121 | - |
dc.identifier.wosid | 000947533100001 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Medicine, v.12, no.5 | - |
dc.citation.title | Journal of Clinical Medicine | - |
dc.citation.volume | 12 | - |
dc.citation.number | 5 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | PLAQUE PSORIASIS | - |
dc.subject.keywordPlus | PLASMA GELSOLIN | - |
dc.subject.keywordPlus | SEVERITY | - |
dc.subject.keywordAuthor | gelsolin | - |
dc.subject.keywordAuthor | mass spectrometry | - |
dc.subject.keywordAuthor | proteomics | - |
dc.subject.keywordAuthor | psoriasis vulgaris | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.